bpc-157 fda warning news 2025 october adcomm votes in favor of lifting restrictions on popular wellness peptide On August 15 2025, the
On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. FDA moves toward easing restrictions on certain peptides BioPharma Dive The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian This Week at FDA: New international partnerships, UniQure and Moderna reversals, and more RAPS
Pay in 4 interest-free payments of $5.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



